相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225T, del226-232 mutation
Domenica Battaglia et al.
PEDIATRIC DIABETES (2012)
Muscle Dysfunction Caused by a KATP Channel Mutation in Neonatal Diabetes Is Neuronal in Origin
Rebecca H. Clark et al.
SCIENCE (2010)
EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2
Oezlem L. Kapucu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation
A. S. Slingerland et al.
DIABETIC MEDICINE (2008)
A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications
P. Tammaro et al.
DIABETOLOGIA (2008)
The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy
Joseph C. Koster et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11
Woj Ciech Mlynarski et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2007)
Transfer to sulphonylurea therapy in adult subiects with permanent neonatal diabetes due to KCNJ1-activating mutations - Evidence for improvement in insulin sensitivity
Maciej T. Malecki et al.
DIABETES CARE (2007)
Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes
Christophe A. J. Girard et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2006)
Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene
A. S. Slingerland et al.
DIABETOLOGIA (2006)
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Ewan R. Pearson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features
Anna L. Gloyn et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2006)
Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects
Kenju Shimomura et al.
DIABETES (2006)
Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels
P Tammaro et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Functional effects of KCNJ11 mutations causing neonatal diabetes:: enhanced activation by MgATP
P Proks et al.
HUMAN MOLECULAR GENETICS (2005)
Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes
AL Gloyn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)